Application of ulinastatin in preparation of drug for treating gallbladder carcinomas

Abstract

The invention belongs to the technical field of medicines, and particularly discloses application of ulinastatin in preparation of a drug for treating gallbladder carcinomas. It is proved through animal experiments that ulinastatin has an obvious inhibiting effect on human gallbladder carcinoma transplanted tumor in nude mice, is low in toxic and side effects and high in safety and can serve as a drug for treating the gallbladder carcinomas for use.

Description

technical field

[0001] The invention belongs to the technical field of medicine, and specifically discloses the use of ulinastatin in the preparation of medicines for treating gallbladder cancer. Background technique

[0002] Gallbladder cancer (carcinoma of the gall-blader) occupies the first place among gallbladder malignant tumors, and other types include sarcoma, carcinoid, primary malignant melanoma, and giant cell adenocarcinoma. Primary gallbladder carcinoma is relatively rare clinically, and has not attracted people's attention for a long time. According to domestic textbook reports, it only accounts for about 1% of all cancers. Due to the extensive development of imaging examinations such as B-ultrasound and CT, gallbladder cancer has been gradually recognized and the detection rate has increased. However, the incidence of gallbladder cancer has obvious regional differences, and the incidence of gallbladder cancer patients is 2 to 4 times higher in women than in me...